| Literature DB >> 26916933 |
Sara E Canavati1, Harriet L S Lawford2, Bayo S Fatunmbi3, Dysoley Lek4, Narann Top-Samphor5, Rithea Leang6, Arjen M Dondorp7, Rekol Huy8, Walter M Kazadi9.
Abstract
BACKGROUND: Countries of the greater Mekong subregion have made a transition from malaria control to an aim for falciparum and vivax malaria elimination. The elimination of falciparum malaria will have to be achieved against a background of increasing artemisinin and multi-drug resistance. This ambitious goal requires an operational research (OR) agenda that addresses the dynamic challenges encountered on the path to elimination, which will need to be flexible and developed in close relation with the cambodian national programme for parasitology, entomology and malaria control (CNM). In Cambodia, a number of meetings with stakeholders were convened by the CNM and emergency response to artemisinin resistance (ERAR) hub, producing an initial list of priority OR topics. The process and outcome of these meetings are described, which could serve as a template for other countries in the region.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26916933 PMCID: PMC4766599 DOI: 10.1186/s12936-016-1117-9
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Specific research areas identified, by thematic area
| Thematic area | Research areas |
|---|---|
| Malaria epidemiology, surveillance and response | Mapping of mobile migrant populations (MMPs) (malaria burden in MMPs; Information on MMP status for every case in the MIS; prophylaxis for malaria control in MMP) |
| Improved case surveillance (case-based surveillance with GIS (low endemic settings); detailed malaria risk maps; Real time cross-border surveillance to be used by both the countries; follow up surveillance for directly observed therapy (DOT) adherence) | |
| Malaria case management | Asymptomatic cases and active surveillance and treatment |
| Feasibility of conducting DOTs for malaria cases | |
| Use of microscopy as a primary method of laboratory confirmed diagnosis for malaria and establishment of a quality control program | |
| Control of malaria vectors | Vector Mapping—Changing environment/Epidemiology/variation across the country requires research into vectors (changing biting patters, life-cycle, species, exo/endophilic, etc.) |
| Insecticide resistance: research into potential pyrethroid resistance/insecticide efficacy | |
| Bed net research—Good national coverage, but how effective are they, are they protecting the most at risk populations (mobile migrant workers); Sleeping behaviour of the net use net preference studies (hammocks, texture, colour) | |
| Malaria behavioural issues | How Does DOT change behaviour of the patients? Adherence of DOTs |
| Huge investments in DOTs—are they worth it? | |
| How can we increase participatory village interventions? Active community involvement? | |
| How can we increase the malaria education provided to patients by health facilities/village malaria workers (VMW)? | |
| How best to communicate with MMPs/forest goers? | |
| Malaria clinical studies | New ACTs drug efficacy, Artesunate + Pyronaridine |
| First line treatment drug efficacy ( | |
| Safety of primaquine (G6PD Screening) | |
| Other vector borne diseases (Dengue, NTDs and STHs) | Dengue/chikungunya surveillance and estimation of disease burden—lacking in adult and private sector |
| To determine a sustainable, effective and ecologically safe vector control measure for dengue control | |
| NTD surveillance and estimation of disease burden—lacking in private sector | |
| NTD surveillance and vector control |
Scoring criteria for prioritization
| SCORE | Minimum | Moderate | High |
|---|---|---|---|
|
|
|
| |
| Significance to malaria elimination | The OR question does not have any significance in terms of malaria elimination | The OR question is reasonably significant in terms of malaria elimination | The OR question is a priority in terms of malaria elimination |
| Feasibility of scaling up nationwide | The OR question does not have any potential to scale up nation wide | The OR question is likely to be scaled up nation wide | The OR question can be easily scaled up nation wide |
| Capacity | There is no capacity in place to implement the OR | There is some capacity in place to implement the OR | There is strong capacity in place to implement the OR |
| Potential for funding | The OR question could have some potential for funding | The OR question has some potential for funding | The OR question has potential for funding |
| Political will | There is no political will to address the OR question | There is some political will to address the OR question | There is high political committed to address the OR question |
| Urgency | There is no urgency to address the OR question in the context of malaria elimination | There is considerable urgency to address the OR question in the context of malaria elimination | There is extreme urgency to address the OR question in the context of malaria elimination |
Operational research topics identified and scored
| Thematic area | Operational research topic | Significance to malaria elimination | Feasibility of scaling up nationwide | Capacity | Potential for funding | Political will | Urgency | Total |
|---|---|---|---|---|---|---|---|---|
| 1. Malaria epidemiology, surveillance and response | MMP surveillance | 3 | 2 | 2 | 3 | 3 | 3 | 16 |
| Improved case surveillance | 3 | 2 | 2 | 3 | 3 | 3 | 16 | |
| 2. Malaria case management | Asymptomatic cases and active surveillance and treatment | 3 | 2 | 2 | 3 | 2 | 3 | 15 |
| Feasibility of conducting DOTs for malaria cases | 2 | 1 | 2 | 2 | 2 | 2 | 11 | |
| Use of microscopy as a primary method of laboratory confirmed diagnosis for malaria and establishment of a quality control program | 2 | 3 | 2 | 1 | 1 | 2 | 11 | |
| 3. Control of malaria vectors | Vector Mapping—changing environment/epidemiology/variation across the country requires research into vectors (changing biting patters, life‐cycle, species, exo/endophilic, etc., insecticide resistance) | 3 | 2 | 2 | 3 | 2 | 3 | 15 |
| Bed net research—good national coverage, but how effective are they, are they protecting the most at risk populations (mobile migrant workers); sleeping behaviour of the net use net preference studies (hammocks, texture, colour) | 3 | 3 | 2 | 1 | 1 | 3 | 13 | |
| 4. Malaria behavioural issues | How does DOTs change behaviour of the patients? Adherence of DOTs | 2 | 3 | 3 | 2 | 3 | 2 | 15 |
| How can we increase participatory village interventions? Active community involvement such as active case detection? | 3 | 3 | 3 | 3 | 3 | 3 | 18 | |
| How can we increase the malaria education provided to patients by health facilities/VMWs? | 3 | 3 | 3 | 2 | 3 | 3 | 7 | |
| How best to communicate with MMPs/forest goers? | 3 | 2 | 2 | 3 | 2 | 3 | 15 | |
| 5. Malaria clinical studies | First line treatment drug efficacy ( | 3 | 3 | 3 | 2 | 3 | 2 | 16 |
| New ACTs drug efficacy, Artesunate + Pyronaridine | 3 | 1 | 3 | 3 | 1 | 3 | 14 | |
| Safety of primaquine (G6PD screening) | 3 | 3 | 3 | 1 | 2 | 3 | 15 | |
| 6. Other vector borne diseases (Dengue, NTDs, STHs) | Dengue/Chikungunya surveillance and estimation of disease burden—lacking in adult and private sector | 2 | 2 | 2 | 1 | 2 | 3 | 12 |
| To determine a sustainable, effective and ecologically safe vector control measure for dengue control | 3 | 1 | 1 | 1 | 1 | 3 | 10 | |
| NTD surveillance and estimation of disease burden—lacking in private sector | N/ A | N/A | N/A | N/A | N/A | N/A | 0 | |
| NTD surveillance and vector control | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
Operational research topics ranked by scoring criteria
| No | OR Topic | Score |
|---|---|---|
| 1 | How can we increase participatory village interventions in active community involvement such as ACD and treatment? | 18 |
| 2 | How can we increase the quality and effectiveness of malaria education provided to patients by health facilities/VMWs, to improve awareness of, and prevention measures against malaria? | 17 |
| 3 | What are the most effective means of improving MMP Surveillance? | 16 |
| 4 | What are the most effective means of improving malaria case surveillance | 16 |
| 5 | Monitoring the efficacy of A + M for the treatment of | 16 |
| 6 | Evaluation of active surveillance and treatment of asymptomatic malaria cases | 15 |
| 7 | How has the epidemiology of vectors changed over the past 10 years? | 15 |
| 8 | How does DOTs change the behaviour of the patients and their adherence to anti-malarials? | 15 |
| 9 | How safe is primaquine administration in Cambodia, and what is the role of G6PD Screening? | 15 |
| 10 | Monitoring the efficacy of novel ACTs (Artesunate + Pyronaridine) in drug resistant regions of Cambodia | 14 |
| 11 | How effective are LLINs in protecting the most at risk populations (mobile migrant workers), and how does net preference and sleeping behaviour affect their use? | 13 |
| 12 | What is the prevalence of dengue and chikungunya in Cambodia? | 12 |
| 13 | How feasible is it to DOTs for malaria cases in Cambodia? | 11 |
| 14 | Is it feasible to use microscopy as a primary method of laboratory confirmed diagnosis for malaria and can a quality control program be established? | 11 |
| 15 | Is there a sustainable, effective and ecologically safe alternative to Abate for vector control measure for dengue control? | 10 |
| 16 | How can the capacity of the private sector be improved to incorporate NTD surveillance and the estimation of disease burden? | 0 |
| 17 | What surveillance and vector control methods are needed for NTDs in Cambodia? | 0 |
Fig. 1Challenges facing operational research activities in Cambodia